about
Impact of albumin on drug delivery--new applications on the horizon.Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I.Design, synthesis and pharmacophoric model building of new 3-alkoxymethyl/3-phenyl indole-2-carboxamides with potential antiproliferative activity.Optimization of an albumin-binding prodrug of Doxorubicin that is cleaved by prostate-specific antigen.The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib.Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model.Zinc oxide nanoparticles as a novel anticancer approach; in vitro and in vivo evidence.Development and optimization of a novel drug free nanolipid vesicular system for treatment of osteoarthritis.Expression profiles of TRPV1, TRPV4, TLR4 and ERK1/2 in the dorsal root ganglionic neurons of a cancer-induced neuropathy rat model.Design, synthesis, docking studies and biological evaluation of novel chalcone derivatives as potential histone deacetylase inhibitors.A Novel Model of Cancer-Induced Peripheral Neuropathy and the Role of TRPA1 in Pain TransductionImplication of umbilical cord in preeclampsiaLesional and circulating levels of interleukin-17 and 25-hydroxycholecalciferol in active acne vulgaris: Correlation to disease severityDesign And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular CarcinomaValidation of the Diagnostic and Prognostic Values of ADAMTS5 and FSTL1 in Osteoarthritis Rat Model
P50
Q34035346-D864B98A-2E8F-4D46-93A2-86F4500F1313Q37359743-57A96F42-706E-4523-A39F-ACA84F6CD139Q38778055-B008C1A6-65BC-49CB-A7C3-87CAD0C4493BQ39155763-D9A96183-A1E7-4C25-B9DC-933548B68D4BQ40483394-FFC380C4-E752-44A0-A659-46F074B065C2Q46616340-09D1D34D-D12D-45A6-9F6D-ADDEB06C4801Q48314069-3B3D011A-876C-484B-9376-960DE036FB7AQ50054138-1227C510-1EB7-4178-B16C-7D392F96FF3CQ52805513-EE64E82D-D282-456B-8E2A-748AE4C2EDBEQ53398019-E39A3A94-1B47-4950-AFF5-E1250DCAA91FQ56983795-DDAD2C48-A3DE-4409-973C-7080B4847522Q83254474-D827BE09-64CA-4DF8-BEA4-32E1391D0D21Q90705949-62FCD252-5E9D-451A-BEFF-3BB8662CCF3BQ91387017-FB892B27-5918-4750-971B-F31F32E5E4D2Q92612095-26489B76-511D-48AD-8303-2549D3722100
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Bakheet El-Kot M Elsadek
@en
Bakheet El-Kot M Elsadek
@nl
type
label
Bakheet El-Kot M Elsadek
@en
Bakheet El-Kot M Elsadek
@nl
prefLabel
Bakheet El-Kot M Elsadek
@en
Bakheet El-Kot M Elsadek
@nl
P31
P496
0000-0001-5444-0245